WDC
38
-3
CSX
68
3
PM
58
2
KSS
42
-3
JBHT
63
-5
AON
60
2
FLR
48
3
LNC
45
-4
KLAC
45
-4
CNP
50
-2
NKE
33
2
DTE
38
-4
DG
12
2
ADM
24
2
PFG
50
-2
VNO
60
8
TEL
74
3
LOW
58
2
DD
61
4
UA
57
4
WDC
38
-3
CSX
68
3
PM
58
2
KSS
42
-3
JBHT
63
-5
AON
60
2
FLR
48
3
LNC
45
-4
KLAC
45
-4
CNP
50
-2
NKE
33
2
DTE
38
-4
DG
12
2
ADM
24
2
PFG
50
-2
VNO
60
8
TEL
74
3
LOW
58
2
DD
61
4
UA
57
4
Financhill
Back

Catalyst Pharmaceuticals 10K Form

Buy
53

CPRX
Catalyst Pharmaceuticals

Last Price:
21.68
Seasonality Move:
4.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $398.2M
Cash Flow: $72.61M
Price / Cash Flow: 12.65
Annual Sales: $5.54
Price / Book: 4.16

Profitability

EPS (TTM): 1.18000
Net Income (TTM): $142.8M
Gross Margin: $346.24M
Return on Equity: 27.81%
Return on Assets: 23.73%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
  • The Research & Development expenses have been 23.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.11
Quick Ratio: 4.75

Price-to-Earnings

Trailing P/E Ratio: 36.57
Forward P/E Ratio: 11

CPRX Technical Analysis vs Fundamental Analysis

Buy
53
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy or a Sell?